SLC9A3 and diabetic kidney disease: NHE3 expression has been positively correlated to diabetic nephropathy since 1986 [11], and its role is confirmed by clinical evidence of increased tubular reabsorption in Type 1 [12] and Type 2 [13] diabetic patients.